U.S. markets closed

Soaring Eagle Acquisition Corp. (SRNGU)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
10.25-0.01 (-0.10%)
At close: 4:00PM EDT

10.29 +0.04 (0.39%)
After hours: 7:29PM EDT

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Previous Close10.26
Bid10.21 x 2900
Ask10.26 x 800
Day's Range10.21 - 10.30
52 Week Range9.90 - 11.29
Avg. Volume3,870,858
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more

      SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Soaring Eagle Acquisition Corp. (Nasdaq - SRNG)

      BALA CYNWYD, PA / ACCESSWIRE / May 11, 2021 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Aurora Acquisition Corp. ("Aurora" or the "Company") (NASDAQ:SRNG) for possible breaches of fiduciary duty and other violations of federal and state law in connection with a merger agreement pursuant to which Aurora, a special purpose acquisition company, will combine with Ginkgo Bioworks, Inc.

    • Ginkgo Bioworks to Become a Public Company and Expand its Leading Platform for Cell Programming
      PR Newswire

      Ginkgo Bioworks to Become a Public Company and Expand its Leading Platform for Cell Programming

      Business combination with Soaring Eagle Acquisition Corp. (Nasdaq:SRNG) values Ginkgo Bioworks, Inc. at a $15 billion pre-money equity valuation and is expected to provide up to $2.5 billion of primary proceeds.

    • Business Wire

      Soaring Eagle Acquisition Corp., Led by Eagle Equity Partners’ Harry Sloan, Jeff Sagansky and Eli Baker Announces Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about April 19, 2021

      Soaring Eagle Acquisition Corp. (the "Company"), the seventh public acquisition vehicle led by Eagle Equity Partners’ Harry Sloan, Jeff Sagansky and Eli Baker, today announced that holders of the units sold in the Company’s initial public offering of 172,500,000 units completed on February 26, 2021 (the "offering") may elect to separately trade the Class A ordinary shares and warrants included in the units commencing on or about April 19, 2021. Any units not separated will continue to trade on the Nasdaq Capital Market (the "Nasdaq") under the symbol "SRNGU," and each of the Class A ordinary shares and warrants will separately trade on the Nasdaq under the symbols "SRNG" and "SRNGW," respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to separate the units into Class A ordinary shares and warrants.